Lowest-Rated StocksLowest-RatedNASDAQ:MRNA Moderna (MRNA) Insider Trading & Ownership $100.23 -3.30 (-3.19%) (As of 03:15 PM ET) Add Compare Share Share Today's Range$100.07▼$103.5950-Day Range$96.41▼$126.6152-Week Range$95.02▼$217.25Volume2.15 million shsAverage Volume3.62 million shsMarket Capitalization$38.15 billionP/E Ratio36.99Dividend YieldN/APrice Target$155.52 Insider TradesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Moderna (NASDAQ:MRNA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage15.70%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$263.18 M Get MRNA Insider Trade Alerts Want to know when executives and insiders are buying or selling Moderna stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MRNA Insider Buying and Selling by Quarter Moderna Insider Trades History Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails9/15/2023Stephen HogePresidentSell15,000$112.99$1,694,850.001,574,187 9/13/2023Noubar AfeyanDirectorSell15,000$109.70$1,645,500.002,221,931 9/8/2023Shannon Thyme KlingerInsiderSell557$107.22$59,721.547,215 9/6/2023Noubar AfeyanDirectorSell15,000$107.61$1,614,150.001,982,209 9/5/2023Shannon Thyme KlingerInsiderSell115$111.44$12,815.606,634 8/30/2023Noubar AfeyanDirectorSell15,000$115.46$1,731,900.001,997,209 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 8/29/2023Stephen HogePresidentSell1,135$115.01$130,536.351,588,855 8/23/2023Noubar AfeyanDirectorSell15,000$115.51$1,732,650.002,012,209 8/17/2023Stephen HogePresidentSell15,000$100.00$1,500,000.001,587,579 8/16/2023Noubar AfeyanDirectorSell10,000$97.56$975,600.002,027,209 8/10/2023Stephen HogePresidentSell247$102.53$25,324.911,602,579 8/2/2023Noubar AfeyanDirectorSell15,000$110.99$1,664,850.002,037,209 7/26/2023Noubar AfeyanDirectorSell15,000$120.42$1,806,300.002,052,209 7/19/2023Noubar AfeyanDirectorSell15,000$125.48$1,882,200.002,067,209 7/17/2023Stephen HogePresidentSell15,000$120.60$1,809,000.001,602,303 7/12/2023Noubar AfeyanDirectorSell15,000$125.81$1,887,150.002,082,209 7/5/2023Noubar AfeyanDirectorSell15,000$124.73$1,870,950.002,097,209 6/28/2023Noubar AfeyanDirectorSell15,000$121.54$1,823,100.002,112,209 6/28/2023Stephane BancelCEOSell27,155$121.63$3,302,862.655,411,946 6/21/2023Noubar AfeyanDirectorSell15,000$121.95$1,829,250.002,127,209 6/21/2023Stephane BancelCEOSell40,000$121.98$4,879,200.005,411,946 6/15/2023Stephen HogePresidentSell15,000$125.93$1,888,950.001,617,303 6/14/2023Stephane BancelCEOSell40,000$126.14$5,045,600.005,411,946 6/7/2023Noubar AfeyanDirectorSell15,000$125.91$1,888,650.002,157,209 6/2/2023Shannon Thyme KlingerInsiderSell110$130.32$14,335.205,942 6/2/2023Stephen HogePresidentSell309$130.32$40,268.881,632,303 5/31/2023Noubar AfeyanDirectorSell15,000$127.35$1,910,250.002,172,209 5/31/2023Stephane BancelCEOSell40,000$126.91$5,076,400.005,411,946 5/30/2023Stephen HogePresidentSell1,181$124.95$147,565.951,631,961 5/24/2023Stephane BancelCEOSell40,000$131.43$5,257,200.005,411,946 5/10/2023Stephane BancelCEOSell40,000$131.60$5,264,000.005,411,946 5/10/2023Stephen HogePresidentSell250$133.37$33,342.501,630,732 4/27/2023Stephane BancelCEOSell40,000$130.61$5,224,400.005,411,946 4/20/2023Stephane BancelCEOSell40,000$142.99$5,719,600.005,411,946 4/12/2023Stephane BancelCEOSell40,000$156.68$6,267,200.005,411,946 4/5/2023Stephane BancelCEOSell40,000$154.64$6,185,600.005,411,946 3/30/2023Stephane BancelCEOSell40,000$148.63$5,945,200.005,411,946 3/22/2023Stephane BancelCEOSell40,000$150.25$6,010,000.005,411,946 3/16/2023Stephane BancelCEOSell40,000$150.87$6,034,800.005,411,946 3/9/2023Stephane BancelCEOSell40,000$139.20$5,568,000.005,411,946 3/8/2023Shannon Thyme KlingerInsiderSell561$141.51$79,387.115,820 3/2/2023Shannon Thyme KlingerInsiderSell459$136.43$62,621.375,243 3/2/2023Stephane BancelCEOSell40,000$137.50$5,500,000.005,411,946 3/1/2023Noubar AfeyanDirectorSell10,000$139.00$1,390,000.002,187,209 3/1/2023Stephen HogePresidentSell1,072$138.03$147,968.161,629,031 2/22/2023Noubar AfeyanDirectorSell10,000$160.35$1,603,500.002,197,209 2/16/2023Stephane BancelCEOSell40,000$173.07$6,922,800.005,411,946 2/15/2023Noubar AfeyanDirectorSell10,000$173.17$1,731,700.002,207,209 2/10/2023Stephen HogePresidentSell245$163.90$40,155.501,627,693 2/8/2023Noubar AfeyanDirectorSell20,000$167.84$3,356,800.002,217,209 2/8/2023Stephane BancelCEOSell40,000$166.00$6,640,000.005,411,946 1/26/2023Stephane BancelCEOSell40,000$190.67$7,626,800.005,411,946 1/25/2023Noubar AfeyanDirectorSell10,000$194.33$1,943,300.002,237,209 1/19/2023Stephane BancelCEOSell40,000$192.06$7,682,400.005,411,946 1/18/2023Noubar AfeyanDirectorSell10,000$200.20$2,002,000.002,247,209 1/11/2023Noubar AfeyanDirectorSell10,000$188.57$1,885,700.002,257,209 1/11/2023Stephane BancelCEOSell40,000$185.02$7,400,800.005,411,946 1/4/2023Noubar AfeyanDirectorSell10,000$182.15$1,821,500.002,267,209 1/4/2023Stephane BancelCEOSell40,000$178.11$7,124,400.005,411,946 12/29/2022Stephane BancelCEOSell40,000$179.85$7,194,000.005,411,946 12/28/2022Juan AndresInsiderSell2,000$180.00$360,000.0012,803 12/22/2022Stephane BancelCEOSell40,000$205.31$8,212,400.005,411,946 12/21/2022Juan AndresInsiderSell2,000$201.70$403,400.0012,803 12/21/2022Noubar AfeyanDirectorSell10,000$201.70$2,017,000.002,277,209 12/14/2022Noubar AfeyanDirectorSell10,000$195.00$1,950,000.002,287,209 12/7/2022Juan AndresInsiderSell2,000$172.16$344,320.0012,803 12/7/2022Noubar AfeyanDirectorSell10,000$172.16$1,721,600.002,297,209 11/30/2022Noubar AfeyanDirectorSell10,000$173.52$1,735,200.002,307,209 11/29/2022Juan AndresInsiderSell814$173.80$141,473.2012,803 11/29/2022Stephen HogePresidentSell1,085$173.80$188,573.001,627,416 11/25/2022Stephane BancelCEOSell40,000$176.04$7,041,600.005,411,946 11/23/2022Juan AndresInsiderSell2,000$178.01$356,020.0011,809 11/23/2022Noubar AfeyanDirectorSell10,000$178.01$1,780,100.002,317,209 11/23/2022Stephane BancelCEOSell40,000$176.20$7,048,000.005,411,946 11/16/2022Noubar AfeyanDirectorSell10,000$184.25$1,842,500.002,327,209 11/9/2022Noubar AfeyanDirectorSell10,000$162.50$1,625,000.002,337,209 11/3/2022Stephane BancelCEOSell40,000$147.10$5,884,000.005,411,946 11/2/2022Juan AndresInsiderSell2,000$154.20$308,400.0011,566 11/2/2022Noubar AfeyanDirectorSell10,000$154.20$1,542,000.002,347,209 10/28/2022Juan AndresInsiderSell4,000$150.00$600,000.0011,566 10/26/2022Noubar AfeyanDirectorSell10,000$137.25$1,372,500.002,357,209 10/26/2022Stephane BancelCEOSell40,000$142.51$5,700,400.005,411,946 10/20/2022Stephane BancelCEOSell40,000$120.83$4,833,200.005,411,946 10/19/2022Noubar AfeyanDirectorSell10,000$132.50$1,325,000.002,367,209 10/12/2022Noubar AfeyanDirectorSell10,000$135.36$1,353,600.002,377,209 10/12/2022Stephane BancelCEOSell40,000$132.28$5,291,200.005,411,946 10/5/2022Noubar AfeyanDirectorSell10,000$122.40$1,224,000.002,387,209 10/5/2022Stephane BancelCEOSell40,000$124.27$4,970,800.005,411,946 9/28/2022Noubar AfeyanDirectorSell10,000$123.58$1,235,800.002,397,209 9/28/2022Stephane BancelCEOSell40,000$123.06$4,922,400.005,411,946 9/22/2022Stephane BancelCEOSell40,000$124.75$4,990,000.005,411,946 9/21/2022Noubar AfeyanDirectorSell10,000$130.37$1,303,700.002,407,209 (Data available from 1/1/2013 forward) MRNA Insider Trading Activity - Frequently Asked Questions Who is on Moderna's Insider Roster? The list of insiders at Moderna includes David W Meline, Juan Andres, Lori M Henderson, Noubar Afeyan, Paul Sagan, Shannon Thyme Klinger, Stephane Bancel, Stephen Hoge, and Tal Zvi Zaks. Learn more on insiders at MRNA. What percentage of Moderna stock is owned by insiders? 15.70% of Moderna stock is owned by insiders. Learn more on MRNA's insider holdings. Which Moderna insiders have been selling company stock? The following insiders have sold MRNA shares in the last 24 months: David W Meline ($147,691.91), Juan Andres ($87,225,632.04), Noubar Afeyan ($97,934,100.00), Paul Sagan ($708,525.00), Shannon Thyme Klinger ($481,948.94), Stephane Bancel ($337,669,092.65), and Stephen Hoge ($79,692,197.55). How much insider selling is happening at Moderna? Insiders have sold a total of 3,469,676 Moderna shares in the last 24 months for a total of $603,859,188.09 sold. More Insider Trading Tools from MarketBeat Related Companies: Seagen Insider Trades Biogen Insider Trades Neurocrine Biosciences Insider Trades Bio-Techne Insider Trades Gilead Sciences Insider Trades Amgen Insider Trades IQVIA Insider Trades IDEXX Laboratories Insider Trades Centene Insider Trades DexCom Insider Trades Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Institutions and Insiders Are Gobbling Up Shares of HASIInsiders Are Buying These 2 Stocks3 Health Companies with Healthy Insider Buying and Market Support2 Cheap Stocks The Insiders Are Buying 3 Stocks to Buy After Heavy Insider Buying This page (NASDAQ:MRNA) was last updated on 9/21/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moderna, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.